Skip to main navigation
Email Alerts
RSS Feeds
XWell Group
  • Home
  • Portfolio
    • XpresSpa
    • Treat
    • XpresCheck
    • HyperPointe
  • News
  • Team
  • Investors
    • Overview
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Events
    • Presentations
    • FAQ
  • Careers & Values
  • Contact Us
  • Home
  • Portfolio
    • XpresSpa
    • Treat
    • XpresCheck
    • HyperPointe
  • News
  • Team
  • Investors
    • Overview
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Events
    • Presentation
    • FAQ
  • Careers & Values
  • Contact Us
  • Media
  • Press Releases

News

10/24/2022
XpresSpa Group Announces New Corporate Identity
9/21/2022
XpresSpa Group Expands Retail Products for Women, Underscoring Company’s Commitment to Support Women’s Health and Wellness
8/15/2022
XpresSpa Group Reports Second Quarter 2022 Results
8/15/2022
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC’s Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
8/12/2022
XpresSpa Group Announces the Re-Opening of XpresSpa™ Location at John F. Kennedy International Airport’s Terminal 4
8/10/2022
XpresSpa Group to Announce Second Quarter 2022 Financial Results on Monday, August 15
7/11/2022
XpresSpa Group Announces Plan for Expansion Internationally
6/14/2022
XpresSpa Group Announces the Separation of Service of Chief Financial Officer James Berry
5/20/2022
XpresSpa Group, Inc. Announces 10 Million Share Increase in Stock Repurchase Program
5/16/2022
XpresSpa Group Reports First Quarter 2022 Results
  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
XWell Group
© 2023 XWELL, Inc. All rights reserved.
Privacy Center | Privacy Policy | Terms and Conditions | Careers
NASDAQ SYMBOL:
  • Price | Change